Globus Medical, Inc.
GMED
Rang in Aktien
#2037
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Aktienkurs
$75.83
Marktkapitalisierung
$10.18B
Veränderung (1 Tag)
-1.04%
Veränderung (1 Jahr)
27.27%
Land
US
Handel Globus Medical, Inc. (GMED)
Kategorie
Healthcare
EPS für Globus Medical, Inc. (GMED)
EPS zum June 2026 TTM: $3.97
Laut den aktuellen Finanzberichten und dem Aktienkurs von Globus Medical, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $3.97. Am Ende des Jahres 2023 betrug das EPS $1.09 ein Rückgang im Vergleich zu dem EPS von 2022, das $1.89 betrug.
EPS-Verlauf von Globus Medical, Inc. von 2009 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $3.97 | 422.37% |
| 2024 | $0.76 | -30.28% |
| 2023 | $1.09 | -42.33% |
| 2022 | $1.89 | 27.70% |
| 2021 | $1.48 | 42.31% |
| 2020 | $1.04 | -33.76% |
| 2019 | $1.57 | -1.88% |
| 2018 | $1.60 | 42.86% |
| 2017 | $1.12 | 2.75% |
| 2016 | $1.09 | -8.40% |
| 2015 | $1.19 | 21.43% |
| 2014 | $0.98 | 32.43% |
| 2013 | $0.74 | -9.76% |
| 2012 | $0.82 | -2.38% |
| 2011 | $0.84 | 12.00% |
| 2010 | $0.75 | 36.36% |
| 2009 | $0.55 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $3.11 | -21.66% |
US
|
|
| $3.59 | -9.57% |
IE
|
|
| $9.73 | 145.09% |
US
|
|
| $2.48 | -37.53% |
US
|
|
| - | - |
DE
|
